Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic sites and comparison with other cyclic AMP-binding proteins

E Butt, J Beltman, DE Becker, GS Jensen, SD Rybalkin, B Jastorff and JA Beavo

Universitat Wurzburg, Klinische Forschergruppe, Germany.

To define essential interactions of cAMP with the catalytic sites of cyclic nucleotide phosphodiesterases (PDEs) and to begin to map the topology of the sites, we have tested a series of cAMP analogs as competitive inhibitors of the PDEs that hydrolyze cAMP with high efficiency (PDE1, PDE2, PDE3, and PDE4). Comparisons of IC50 values, relative to cAMP, were used to predict which functional groups on cAMP interact with each isozyme. Common to all PDEs tested, except for the calcium/calmodulin-dependent PDE (CaM-PDE, PDE1), is an interaction at the N1-position of cAMP and a distinct lack of binding to the 2'- hydroxyl group of the ribose moiety. Only the cGMP-stimulated (PDE2) and cAMP-specific (PDE4) PDEs appear to interact strongly at the N7- position. The cGMP-inhibited PDE (cGI-PDE, PDE3) may interact less strongly with this nitrogen. The PDE4 and PDE3 both interact with cAMP through the 6-amino group, which most likely serves as a hydrogen bond donor. PDE4 and PDE3 appear to be able to bind to the anti-conformer of cAMP, whereas the PDE1 and PDE2 bind the syn-conformer. The CaM-PDE exhibits no appreciable specificity for any of the analogs tested, showing little or no interaction with the 6-amino group or with any of the ring nitrogens. Large differences exist in the nucleotide-binding requirements for the PDE catalytic sites, compared with the regulatory sites of cAMP-dependent protein kinase and the catabolite activator protein.

Volume 47, Issue 2, pp. 340-347, 02/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				H. Wang, Y. Liu, J. Hou, M. Zheng, H. Robinson, and H. Ke From the Cover: Structural insight into substrate specificity of phosphodiesterase 10 PNAS, April 3, 2007; 104(14): 5782 - 5787. [Abstract] [Full Text] [PDF]

				A. Boccaccio, L. Lagostena, V. Hagen, and A. Menini Fast Adaptation in Mouse Olfactory Sensory Neurons Does Not Require the Activity of Phosphodiesterase J. Gen. Physiol., July 31, 2006; 128(2): 171 - 184. [Abstract] [Full Text] [PDF]

				Y. Ni, R. Wu, W. Xu, H. Maecke, J. Flammer, and I. O. Haefliger Effect of cAMP on Porcine Ciliary Transepithelial Short-Circuit Current, Sodium Transport, and Chloride Transport Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 2065 - 2074. [Abstract] [Full Text] [PDF]

				M. Sausbier, R. Schubert, V. Voigt, C. Hirneiss, A. Pfeifer, M. Korth, T. Kleppisch, P. Ruth, and F. Hofmann Mechanisms of NO/cGMP-Dependent Vasorelaxation Circ. Res., October 27, 2000; 87(9): 825 - 830. [Abstract] [Full Text] [PDF]

				R. X. Xu, A. M. Hassell, D. Vanderwall, M. H. Lambert, W. D. Holmes, M. A. Luther, W. J. Rocque, M. V. Milburn, Y. Zhao, H. Ke, et al. Atomic Structure of PDE4: Insights into Phosphodiesterase Mechanism and Specificity Science, June 9, 2000; 288(5472): 1822 - 1825. [Abstract] [Full Text] [PDF]

				S. B. Herman, D. M. Juilfs, E. B. Fauman, P. Juneau, and J. P. Menetski Analysis of a Mutation in Phosphodiesterase Type 4 that Alters Both Inhibitor Activity and Nucleotide Selectivity Mol. Pharmacol., May 1, 2000; 57(5): 991 - 999. [Abstract] [Full Text]

				M. Côté, M. D. Payet, E. Rousseau, G. Guillon, and N. Gallo-Payet Comparative Involvement of Cyclic Nucleotide Phosphodiesterases and Adenylyl Cyclase on Adrenocorticotropin-Induced Increase of Cyclic Adenosine Monophosphate in Rat and Human Glomerulosa Cells Endocrinology, August 1, 1999; 140(8): 3594 - 3601. [Abstract] [Full Text]

				M. Kurjak, R. Fritsch, D. Saur, V. Schusdziarra, and H. D. Allescher NO releases bombesin-like immunoreactivity from enteric synaptosomes by cross-activation of protein kinase A Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1521 - G1530. [Abstract] [Full Text] [PDF]

				M. C. Hebert, F. Schwede, B. Jastorff, and R. H. Cote Structural Features of the Noncatalytic cGMP Binding Sites of Frog Photoreceptor Phosphodiesterase Using cGMP Analogs J. Biol. Chem., March 6, 1998; 273(10): 5557 - 5565. [Abstract] [Full Text] [PDF]

				S. Jacobitz, M. D. Ryan, M. M. McLaughlin, G. P. Livi, W. E. Dewolf Jr., and T. J. Torphy Role of Conserved Histidines in Catalytic Activity and Inhibitor Binding of Human Recombinant Phosphodiesterase 4A Mol. Pharmacol., June 1, 1997; 51(6): 999 - 1006. [Abstract] [Full Text]